We found that higher RBP-J expression was associated with lower glioma Grade (P < 0.05), but there was no association between the expression level of RBP-J and other clinicopathological parameters in glioma such as age and gender (P > 0.05). This evidence concerns the gene RBPJ and central nervous system cancer.